FFA
DGX icon

Frazier Financial Advisors’s Quest Diagnostics DGX Stock Holding History

Frazier Financial Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.6K Buy
166
+138
+493% +$26.8K 0.02% 239
2025
Q4 		$4.89K Hold
28
– – ﹤0.01% 467
2025
Q3 		$5.35K Hold
28
– – ﹤0.01% 448
2025
Q2 		$5.02K Hold
28
– – ﹤0.01% 457
2025
Q1 		$4.7K Hold
28
– – ﹤0.01% 442
2024
Q4 		$4.18K Hold
28
– – ﹤0.01% 467
2024
Q3 		$4.27K Buy
28
+1
+4% +$149 ﹤0.01% 555
2024
Q2 		$3.75K Hold
27
– – ﹤0.01% 683
2024
Q1 		$3.63K Hold
27
– – ﹤0.01% 661
2023
Q4 		$3.73K Buy
+27
New +$3.55K ﹤0.01% 564

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Frazier Financial Advisors's DGX Position: Q1 2026 in Review

Frazier Financial Advisors increased its Quest Diagnostics (DGX) stake by 493% in Q1 2026, buying an estimated $26.8K and bringing the position to 166 shares worth $32.6K. The position accounts for 0.02% of the portfolio, ranked #239.

Frazier Financial Advisors first reported a position in DGX in Q4 2023 and has held it in 10 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Frazier Financial Advisors held 166 shares of Quest Diagnostics worth $32.6K as of Q1 2026.
  • Frazier Financial Advisors bought 138 Quest Diagnostics shares in Q1 2026, an estimated $26.8K.
  • Quest Diagnostics made up 0.02% of Frazier Financial Advisors's portfolio in Q1 2026, its #239 holding.
  • Frazier Financial Advisors first reported a position in Quest Diagnostics in Q4 2023 and has held it in 10 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.